Sort
51,593 grants matching “hepatitis”
Follow-Up Studies of a Genome-Wide Association Analysis in Pima Indians
$914,965Leslie J Baier · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Therapeutic targets in African-American youth with type 2 diabetes
$914,529Stephanie Therese Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
HIV and Hepatocellular Carcinoma in Uganda: The H2U Consortium
$914,483Gregory D Kirk · Johns Hopkins University · U54 · FY2018 · CA
NIH: Spatial Models of Intrahepatic Hepatitis Virus Propagation in Humans
$914,165Ruy M Ribeiro · Triad National Security, Llc · R01 · FY2022 · AI
Observation Study of Persons with Chronic Hepatitis B Virus infection in North America
$913,971Harry Janssen · University Health Network · U01 · FY2017 · DK
Ceramides as novel drivers of metabolic dysfunction and colorectal cancer
$913,866Mary Christine Playdon · University Of Utah · U01 · FY2022 · CA
Gene Array Technology Center for Alcohol Research (The R-GAP)
$913,423Boris Tabakoff · University Of Colorado Denver · R24 · FY2009 · AA
Entry and replication of positive-sense, RNA viruses
$912,922Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Discrimination of nonself by innate immune receptors
$912,922Joseph Marcotrigiano · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
RESEARCH CORE
$912,296Chau Trinh-Shevrin · New York University School Of Medicine · P60 · FY2007 · MD
An Orally Delivered Booster Vaccine Candidate for Hepatitis B
$911,830John A. Howard · Applied Biotechnology Institute · R44 · FY2013 · AI
A geospatial analysis of hotspots and targeted injection settings pilot intervention for HIV prevention among people who inject drugs in Baltimore, Maryland
$911,181Carl A Latkin · Johns Hopkins University · R01 · FY2022 · DA
Material-guided delivery and local activation of bioorthogonal prodrugs
$910,710Sangeetha Srinivasan · Tambo, Inc. · R44 · FY2020 · GM
Newborn cohorts to discover and validate biomarkers of neonatal vaccine immunogenicity
$910,412Ofer Levy · Boston Children'S Hospital · U19 · FY2019 · AI
Intervention for Sustained Testing and Retention (iSTAR) Among HIV-infected Patients
$910,125Echezona Edozie Ezeanolue · University Of Nevada Las Vegas · R01 · FY2017 · HD
Novel therapeutics for fatty liver disease and type-II diabetes
$909,785Dave Musso · Southeast Techinventures, Inc. · R44 · FY2014 · DK
Childhood Liver Disease Research Network Data Coordinating Center
$909,424John C Magee · University Of Michigan At Ann Arbor · U24 · FY2020 · DK
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study
$908,642Joshua Aiden Hill · Fred Hutchinson Cancer Center · U01 · FY2022 · CA
Conduct of Studies to Evaluate the Transcriptomic Changes and Toxicologic Potential of Per/Polyfluorinated Alkyl Substances (PFAS) in Laboratory Animals via Gavage
$908,597Barney Sparrow · Battelle Memorial Institute · N01 · FY2020 · ES
Mechanisms of Cellular Transformation by HTLV-1
$907,824Kuan-Teh Jeang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
CD180 targeted immunotherapeutic for chronic HBV in HIV infected patients
$907,661Deborah L. Fuller · University Of Washington · R56 · FY2019 · AI
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
$907,297Byoung-Joon Song · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA
Cooperative Center for the study of HCV antibody responses and vaccine antigens
$907,122Mansun Law · Scripps Research Institute, The · U19 · FY2019 · AI
Integrating HCV services into HIV programs for PWID in India
$907,120Shruti H Mehta · Johns Hopkins University · R01 · FY2023 · AI
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
$907,003Hilde Cheroutre · La Jolla Institute For Immunology · DP1 · FY2013 · GM